TD Asset Management
FPRX

TD Asset Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

TD Asset Management’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-47,157
Closed -$802K – 1580
2020
Q4 		$802K Buy
+47,157
New +$591K ﹤0.01% 1233
2019
Q2 		– Sell
-25,229
Closed -$338K – 1379
2019
Q1 		$338K Buy
25,229
+300
+1% +$3.42K ﹤0.01% 1244
2018
Q4 		$232K Buy
24,929
+200
+0.8% +$2.38K ﹤0.01% 1340
2018
Q3 		$344K Buy
24,729
+200
+0.8% +$2.97K ﹤0.01% 1355
2018
Q2 		$388K Buy
24,529
+300
+1% +$5.24K ﹤0.01% 1317
2018
Q1 		$416K Buy
24,229
+12,729
+111% +$248K ﹤0.01% 1234
2017
Q4 		$252K Buy
+11,500
New +$370K ﹤0.01% 1277
2016
Q1 		– Sell
-14,800
Closed -$614K – 1396
2015
Q4 		$614K Sell
14,800
-13,800
-48% -$463K ﹤0.01% 1059
2015
Q3 		$440K Buy
28,600
+500
+2% +$10.7K ﹤0.01% 1100
2015
Q2 		$698K Hold
28,100
– – ﹤0.01% 1044
2015
Q1 		$642K Buy
28,100
+8,900
+46% +$225K ﹤0.01% 1064
2014
Q4 		$518K Buy
+19,200
New +$330K ﹤0.01% 1089

Other funds holding FPRX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

TD Asset Management's FPRX Position: Q1 2021 in Review

TD Asset Management sold out of Five Prime Therapeutics, Inc. (FPRX) in Q1 2021, closing a stake of 47,157 shares — an estimated $802K sold.

TD Asset Management first reported a position in FPRX in Q4 2014 and held it in 12 quarters. The position peaked at $802K in Q4 2020. 147 funds tracked by Wall St. Rank hold FPRX as of Q1 2021.

  • TD Asset Management reported no remaining Five Prime Therapeutics, Inc. position as of Q1 2021 after selling out during the quarter.
  • TD Asset Management sold 47,157 Five Prime Therapeutics, Inc. shares in Q1 2021, an estimated $802K.
  • TD Asset Management first reported a position in Five Prime Therapeutics, Inc. in Q4 2014 and held it in 12 quarters.
  • TD Asset Management's Five Prime Therapeutics, Inc. position peaked at $802K in Q4 2020.
  • 147 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q1 2021.

Based on TD Asset Management's 13F filing for Q1 2021, filed 14 May 2021.